Tuesday's Action | ARNA Message Board Posts

Arena Pharmaceuticals, Inc.

  ARNA website

ARNA   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  39 of 71  at  5/15/2019 4:02:25 AM  by

link1


 In response to msg 38 by  link1
view thread

Re: Tuesday's Action

Etrasimod a novel, small-molecule, oral S1P receptor modulator in clinical development

Lymphocyte trafficking

March 5 2019:

Work was funded by Arena Pharmaceuticals, Inc.

* honoraria from Merck, Abbvie, Janssen, Genentech, Ferring, Tillotts, Vifor, Pharmacosmos, Celltrion, Takeda, Biogaran, Boehringer-Ingelheim, Lilly, Pfizer, Index Pharmaceuticals, Amgen, Sandoz, Celgene, Biogen, Samsung Bioepis, Alma, Sterna, Nestlé and Enterome

There is an associated report...no access. My guess is the clean small-molecule is very clean.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 0     Views: 125
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
40 Re: Tuesday's Action biobetter 6 5/15/2019 7:47:32 AM


About Us  •  Contact Us  •  Follow Us on Twitter  •  Members Directory  •  Help Center  •  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
© 2003-2019 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...